Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
AnaptysBio, Inc. Banner

AnaptysBio, Inc.

ANAB Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
3.532M-5.405m-4.259m-30.070m-61.656m-97.336m-19.931m-57.796m-128.724m-163.619m
Depreciation & Amortization
308.000K274.000K233.000K183.000K315.000K514.000K559.000K2.090M2.335M2.376M
Change in Working Capital
9.268M-6.532m-7.026m4.075M3.461M16.851M-6.771m-7.489m6.839M-324.000k
Operating Cash Flow
14.603M-9.669m-9.030m-19.438m-48.506m-69.517m-14.157m-45.920m-73.593m-120.800m
Capital Expenditure
-145.000k-238.000k-50.000k-290.000k-1.063m-805.000k-569.000k-1.366m-358.000k-807.000k
Free Cash Flow
14.458M-9.907m-9.080m-19.728m-49.569m-70.322m-14.726m-47.286m-73.951m-121.607m
Debt Repayment
-5.000m0.000-10.000m0.000-6.875m-7.500m-1.375m-72.000k-30.685m-11.726m
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
0.000160.000K31.000K292.537M227.476M3.007M496.000K2.553M11.827M2.472M
Common Stock Repurchased
0.0000.000-1.000k0.0000.0000.0000.0000.0000.000-50.000m
Net Change in Cash
19.378M29.496M-452.000k29.957M32.407M57.421M79.439M245.213M-424.421m-35.343m